BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Ardelyx Inc. (NASDAQ:ARDX)

1 post

Biotech NewsArdelyx (ARDX) Tops Q3 With $110.33M Revenue

  • BioTech Health X
  • December 7, 2025
Ardelyx Inc. (NASDAQ:ARDX) is a commercial-stage biopharmaceutical company focused on developing and delivering first-in-class medicines for patients suffering…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Quantum BioPharma (QNTM) Takes Center Stage as CTV’s W5 Exposes Alleged $700M Stock Manipulation Scheme
  • Amarin (AMRN) Posts 17% Revenue Surge: Is This the Start of a Massive Turnaround?
  • Cadrenal Therapeutics (CVKD) Surges in Attention After Q3 2025 Update Reveals Big Pipeline Moves
  • Ardelyx (ARDX) Tops Q3 With $110.33M Revenue
  • Kymera Therapeutics (KYMR) Jumps 10.2% in a Month—Is Wall Street Pricing in a Major 2026 Breakout?
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • December 7, 2025
    Quantum BioPharma (QNTM) Takes Center Stage as CTV’s W5 Exposes Alleged $700M Stock Manipulation Scheme
    • December 7, 2025
    Amarin (AMRN) Posts 17% Revenue Surge: Is This the Start of a Massive Turnaround?
    • December 7, 2025
    Cadrenal Therapeutics (CVKD) Surges in Attention After Q3 2025 Update Reveals Big Pipeline Moves
    • December 7, 2025
    Ardelyx (ARDX) Tops Q3 With $110.33M Revenue
    • December 6, 2025
    Kymera Therapeutics (KYMR) Jumps 10.2% in a Month—Is Wall Street Pricing in a Major 2026 Breakout?
Recent Posts
  • Biodexa Pharmaceuticals (BDRX) Launches Phase 3 Trial for eRapa — Can This $2.81M Biotech Transform FAP Treatment?
    • December 6, 2025
  • Galectin Therapeutics (GALT) Surges 10.5% After Insider Sells 120,000 Shares
    • December 6, 2025
  • Analysts Boost Target to $24 as Ocular Therapeutix (OCUL) Nears Major Catalyst
    • December 6, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (5)
  • Biotech News (611)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top